Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns

Pediatric Surgery International

Volumn 24, Issue 4, 2008, Pages 425-430

  Uguralp, S ^a   Irsi, C ^a   Aksoy, T ^a   Karabulut, A Bay ^a   Kirimlioglu, H ^a   Mizrak, B ^a  

^a INONU UNIVERSITY   (Turkey)

Author keywords

Caustic; Corrosive; Esophagus; Inflammation; Resveratrol; Stricture

Indexed keywords

CAUSTIC AGENT; COLLAGEN; GLUTATHIONE; MALONALDEHYDE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; RESVERATROL; STILBENE DERIVATIVE;

ANIMAL; ARTICLE; CHEMICAL BURN; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; ESOPHAGITIS; ESOPHAGUS STENOSIS; INFLAMMATION; MALE; METABOLISM; METHODOLOGY; PATHOPHYSIOLOGY; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BURNS, CHEMICAL; CAUSTICS; COLLAGEN; DISEASE MODELS, ANIMAL; ESOPHAGEAL STENOSIS; ESOPHAGITIS; GLUTATHIONE; INFLAMMATION; MALE; MALONDIALDEHYDE; NITRIC OXIDE; RATS; RATS, WISTAR; RESEARCH DESIGN; STILBENES;

EID: 49649116922     PISSN: 01790358     EISSN: 14379813     Source Type: Journal    
DOI: 10.1007/s00383-008-2116-x     Document Type: Article

References (28)

1. Wasserman RL, Ginsburg CM (1985) Caustic substance injuries. J Pediatr 107:169-174 (Pubitemid 15241902)
2. Karnak I, Tanyel FC, Buyukpamukcu N, Hicsonmez A (1999) Combined use of steroid, antibiotics and early bougienage against stricture formation following caustic esophageal burns. J Cardiovasc Surg (Torino) 40:307-310 (Pubitemid 29216850)
3. Günel E, Çaǧlayan F, Çaǧlayan O, Canbilen A, Tosun M (2002) Effect of antioxidant therapy on collagen synthesis in corrosive esophageal burns. Pediatr Surg Int 18:24-27 (Pubitemid 36055858)
4. Arbell D, Udassin R, Koplewitz BZ, Ohana M, Genina O, Pines M, Nagler A (2005) Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis. Laryngoscope 115:1632-1635 (Pubitemid 41330675)
5. Temir ZG, Karkiner A, Karaca I, Ortaç R, Ozdamar A (2005) The effectiveness of sucralfate against stricture formation in experimental corrosive esophageal burns. Surg Today 35:617-622 (Pubitemid 41032279)
6. Yeming W, Somme S, Chenren S, Huiming J, Ming Z, Liu DC (2002) Balloon catheter dilatation in children with congenital and acquired esophageal anomalies. J Pediatr Surg 37:398-402 (Pubitemid 34188162)
7. Günel E, Çaǧlayan F, Çaǧlayan O, Akillioǧlu I (1999) Reactive oxygen radical levels in caustic esophageal burns. J Pediatr Surg 34:405-407
8. Fremont L (2000) Biological effects of resveratrol. Life Sci 66:663-673
9. Johnson JL, Maddipati KR (1998) Paradoxal effects of resveratrol on the two prostaglandin H synthases. Prostaglandins 56:131-143 (Pubitemid 28453273)
10. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CWW, Fong HHS, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (1997) Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275:218-220 (Pubitemid 127696281)
11. Olson ER, Naugle JE, Zhang X, Bomser JA, Meszaros JG (2005) Inhibition of cardiac fibroblast proliferation and myofibroblast differention by resveratrol. Am J Physiol Heart Circ Physiol 288:H1131-H1138 (Pubitemid 40270016)
12. Moreno JJ (2000) Resveratrol modulates arachidonic acid release, prostaglandin synthesis, and 3T6 fibroblast growth. J Pharmacol Exp Ther 294:333-338
13. Chavez E, Reyes-Gordillo K, Segovia J, Shibayama M, Tsutsumi V, Vergara P, Moreno MG, Muriel P (2008) Resveratrol prevents fibrosis, NF- kappa B activation and TGF- beta increases induced by chronic CCI (4) treatment in rats. J Appl Toxicol 28:35-43
14. Gehanno G, Guedon C (1981) Inhibition of experimental esophageallye strictures by penicillamine. Arch Otolaryngol 107:145-147
15. Liu AJ, Richardson AM (1985) Effects of N-Acetylcysteine on experimentally induced esophageal lye injury. Ann Rhinol Laryngol 94:477-481
16. Mihara M, Uchiyama M (1978) Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86:271-278 (Pubitemid 9050395)
17. Fontecave M, Lepoivre M, Elleingand E, Gerez C, Guittet O (1998) Resveratrol, a remarkable inhibitor of ribonucleotide reductase. FEBS Lett 421:277-279 (Pubitemid 28045770)
18. Wennmalm A, Benthin G, Peterson AS (1992) Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell hemoglobin. Br J Pharmacol 106:507-518
19. Cortas NK, Wakid NW (1990) Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 36:1440-1443
20. Millar AJW, Cywes S (1998) Caustic strictures of the esophagus. In: O'Neill JA, Rowe MI, Grosfeld JL (eds) Pediatric surgery. Mosby Year Book Inc, St Louis, pp 970
21. Van der Vliet A, Bast A (1992). Role of reactive oxygen species in intestinal diseases. Free Radic Biol Med 12:499-513
22. Villa P, Soccani A, Sico A, Ghezzi P (2002) Glutathione protects mice from lethal sepsis by limiting inflammation and potentiating host defence. JID 185:1115-1120 (Pubitemid 34297769)
23. Bekyarova G, Yankova T (1998) Alpha-Tocopherol and reduced glutathione deficiency and decreased deformability of erythrocytes after thermal skin injury. Acta Physiol Pharmacol Bulg 23:55-59 (Pubitemid 29104178)
24. Sekhar KR, Spitz DR, Haris S, Nguyen TT, Meredith MJ, Holt JT, Gius D, Marnett LJ, Summer ML, Freeman ML, Guis D (2002) Redox-sensitive interaction between KIAA0132 and Nrf2 mediates indomethacin-induced expression og gamma-glutamylcysteine synthetase. Free Radic Biol Med 32:650-662 (Pubitemid 34241497)
25. Kim SM, Byun JS, Jung YD, Kang IC, Choi SY, Lee KY (1998) The effects of oxygen radicals on the activity of nitric oxide synthase and guanylate cyclase. Exp Mol Med 30:221-226
26. Leiro J, Alvarez E, Garcia D, Orallo F (2002) Resveratrol modulates rat macrophage functions. Int Immunopharmacol 2:767-774 (Pubitemid 34603121)
27. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421-431 (Pubitemid 20279983)
28. Godichaud S, Krisa S, Couronne B, Dubuisson L, Merillon JM, Desmouliere A, Rosenbaum J (2000) Deactivation of cultured human liver myofibroblasts by trans-resveratrol, a grapevine-derived polyphenol. Hepatology 31:922-931 (Pubitemid 30169940)